Why the shift is accelerating
Three forces are compounding. Clinical advances make more procedures safe outside the hospital. Payers have strong cost incentives to steer, and now have the medical-policy and prior-authorization machinery to do it. And Medicare's own site-neutral debates keep the differential between settings in the policy spotlight, which gives commercial payers cover to press the issue.
Site-of-care steering is not a threat to be resisted so much as a shift to be priced. The margin follows the setting — the strategy question is which settings you control.
The economics by setting
| Setting | Relative payment | Payer posture |
|---|---|---|
| Hospital outpatient department (HOPD) | Highest | Steering volume away |
| Ambulatory surgery center (ASC) | Lower than HOPD | Actively favored |
| Office / clinic | Lower still | Favored where clinically appropriate |
| Home / virtual | Lowest | Emerging; expanding coverage |
Illustrative index for discussion; actual differentials vary by procedure, market, and contract.
The differential between HOPD and ASC for the same procedure is often the single largest lever in a payer's outpatient spend — which is exactly why it is the first place they steer.
Shaping the shift
Own the lower-cost site
If payers are going to move volume to ASCs, the strategic response is often to participate in or partner with the ASC rather than defend HOPD volume that will erode regardless.
Reprice deliberately
Model the margin of each high-volume procedure by setting, and negotiate ASC and office rates that make the migration economically neutral or favorable to you — not just to the payer.
Manage the authorization pathway
Site-of-service denials and prior-authorization requirements are where steering actually happens. Clean documentation and a managed authorization process protect appropriate HOPD volume and reduce write-offs.